Loading...
(86)Y based PET radiopharmaceuticals: radiochemistry and biological applications
Development of targeted radionuclide therapy with (90)Y labeled antibodies and peptides has gained momentum in the past decade due to the successes of (90)Y-ibritumomab tiuxetan and (90)Y-DOTA-Phe(1)-Tyr(3)-octreotide in treatment of cancer. (90)Y is a pure β(−)-emitter and cannot be imaged for pati...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3184346/ https://ncbi.nlm.nih.gov/pubmed/21711222 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|